CpG Island Methylator Phenotype is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage 3 Colon Cancer
- Citation:
- Gastroenterology vol 147 (3) 637-645
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 4
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10 CA032291, CA33601, U10 CA077658, T32 DK007742, UO1CA152756, CA32291, P30 CA015704, P01 CA077852, U10 CA031946, CA77651, U10 CA033601, U54 CA143862, CA60138, U10 CA180821, U10 CA037447, U10 CA180850, F32CA1591555-01, U10 CA077651, U54CA143862, T32 CA009515, P01CA077852, 2T32DK007742-16, P01CA77852, CA77658, R01 CA115513, 5T32-CA009515-28/29, R01CA115513, U10 CA180867, U01 CA152756, CA31946, F32 CA159555, P30CA15704
- Corr. Author:
- Stacey Shiovitz
- Authors:
- Stacey Shiovitz Monica M. Bertagnolli Lindsay A. Renfro Eunmi Nam Nathan R. Foster Slavomir Dzieciatkowski Yanxin Luo Victoria Valinluck Lao Raymond J. Monnat Mary J. Emond Nancy Maizels Donna Niedzwiecki Richard M. Goldberg Leonard B. Saltz Alan Venook Robert S. Warren William M. Grady
- Networks:
- Study
- CALGB-89803
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- CALGB (Alliance) 89803, CRC, epigenetic factors, chemotherapy